lintuzumab SGN

Related by string. * : clinical trials lintuzumab SGN . lintuzumab / sgnd . sgn : ASG 5ME dacetuzumab SGN . brentuximab vedotin SGN . Brentuximab Vedotin SGN . clinical trials dacetuzumab SGN . dacetuzumab SGN . clinical trials SGN . SGN Nutrition . Amex SGN . commercialize SGN . symbol SGN . AMEX SGN . SGN * *

Related by context. Frequent words. (Click for all words.) 76 refractory chronic lymphocytic 74 R sorafenib tablets 74 forodesine 74 phase IIb clinical 73 Initiates Phase II 73 Panzem R 73 GVAX R 73 metastatic castration resistant 72 relapsed refractory multiple myeloma 72 advanced carcinoid 71 TELINTRA 71 Allovectin 7 R 70 elotuzumab 70 Initiate Phase 70 metastatic hormone refractory 70 Pivotal Phase III 70 Phase 2b clinical trials 69 multi kinase inhibitor 69 Pivotal Phase 69 Entereg R 69 Fibrillex TM 69 CORT # 69 Completes Enrollment 69 metastatic castrate resistant 68 Phase IIb trials 68 primary hypercholesterolemia 68 liposomal formulation 68 castrate resistant prostate cancer 68 sodium Injection 68 AEG# 68 vosaroxin 68 MKC# 68 Daclizumab 68 PEG SN# 68 phenylalanine ammonia lyase 68 Phase Ib II 67 Presents Positive 67 Initiates Phase 67 registrational trial 67 Phase IIa clinical trials 67 SAR# [004] 67 Ixempra 67 INCB# [001] 67 phase IIa clinical 67 multiple myeloma MM 67 squalamine 67 lymphoma CTCL 67 Commences Phase 67 HGS ETR1 67 Thiarabine 66 6R BH4 66 JAK1 66 non alcoholic steatohepatitis 66 Soliris TM eculizumab 66 Phase Ib clinical 66 phenylketonuria PKU developed 66 Amrubicin 66 Acute Myeloid Leukemia AML 66 Rebif ® 66 plus prednisone 66 phase Ib 66 Epratuzumab 66 CR# vcMMAE 66 IMC #B 66 KRN# 66 RGB # 66 subcutaneous formulation 66 ongoing Phase 1b 66 sunitinib malate 66 drug conjugate 66 axitinib 66 MEK inhibitor 66 ALN TTR# 66 developing Zerenex TM 66 Shigamabs ® 66 dacetuzumab 66 ThermoDox R 66 relapsed multiple myeloma 66 painful diabetic neuropathy 66 Pegasys ® 66 multicenter Phase 66 refractory multiple myeloma 66 Inc. Nasdaq IMGN 66 Genasense ® 66 teriflunomide 66 Traficet EN 66 Vandetanib 66 PEG PAL PEGylated recombinant 66 luteinizing hormone releasing 66 Golimumab 65 registrational 65 MPS IVA 65 Phase 2a clinical 65 deforolimus 65 pegylated interferon alpha 65 Bicifadine 65 Prestara 65 Cloretazine R VNP#M 65 CIMZIA TM 65 TELCYTA 65 Alzhemed TM

Back to home page